Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
57
UMBF Quote, Financials, Valuation and Earnings
Last price:
$102.26
Seasonality move
:
3.07%
Day range:
$100.10 - $102.50
52-week range:
$76.00 - $129.94
Dividend yield:
1.55%
P/E ratio:
11.34x
P/S ratio:
3.41x
P/B ratio:
2.13x
Volume:
422.4K
Avg. volume:
715.4K
1-year change:
28.36%
Market cap:
$7.4B
Revenue:
$1.5B
EPS (TTM):
$8.99
UMB Financial Number of Institutional Trades
UMB Financial Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$5B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$5B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
UMB Financial Institutional Ownership
-
What Percentage Of UMBF Is Owned by Institutions?
-- of UMBF is owned by institutions.
-
How Many Institutions Own UMBF Shares?
UMB Financial stock is owned by 646 institutional shareholders at this time.
-
Have Institutions Been Buying UMBF Stock?
Yes, institutions have bought 22.5M shares of UMBF in the last quarter.
-
Have Institutions Been Selling UMBF Stock?
Yes, institutions have sold 25.4M shares of UMBF over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
